InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Kiritsy Christopher P. Director active across 2 companies, notably Pieris Pharmaceuticals, INC.. In total, 3 reports have been published. Split: 1 buy · 1 sell. Total volume traded: €50k. Activity tracked since 25 May 2023. The latest transaction was disclosed on 2 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条